Budget impact of sequential treatment with first-line afatinib versus first-line osimertinib in non-small-cell lung cancer patients with common EGFR mutations
| Image |  |
|---|---|
| Description | scientific article published on 23 April 2020 |
| Author/s |
author: Lotte Westerink Maarten J. Postma |
| Publication date | April 23, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |